Ari Green, MD, of the University of California, San Francisco, details the benefits of remyelination for patients with multiple sclerosis (MS), as well as the challenges faced when conducting ...

Please provide your email address to receive an email when new articles are posted on . Nearly all patients in the open-label extension of VISIONARY-MS showed MRI evidence of neuronal repair and ...

Rob Etherington drives an electric car with a personalized license plate that reads “CLENE,” as in Clene Nanomedicine, the company he leads as President and CEO: “Many people ask me, is it because ...

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...

The therapeutic landscape for multiple sclerosis (MS) is evolving beyond modulating the peripheral immune response. New strategies are now focussed on reducing inflammation and promoting the ...

Read about the diverse array of research presented at this year's meeting, including novel technological advancements and insights into disease progression in multiple sclerosis (MS). Our top coverage ...

The loss of myelin in the cerebral cortex of multiple sclerosis (MS) patients could be recovered if oligodendrocytes, the cells that myelinate neuronal axons, work at a higher rate than they are ...

In multiple sclerosis (MS), the immune system mistakenly attacks the brain and spinal cord, causing the complete loss of myelin. “Synthesized by specialized cells, oligodendrocytes, myelin protects ...

It was previously demonstrated that the CNS-penetrant compound bryostatin-1 (bryo-1) exerts an immunomodulatory effect on myeloid-lineage innate immune cells in the periphery through its actions on ...